Terms: = Sarcomas AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
10 results:
1. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract] [Full Text] [Related]
2. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
Zhang G; Bi H; Gao J; Lu X; Zheng Y
Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
[TBL] [Abstract] [Full Text] [Related]
4. The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells.
Notaro A; Sabella S; Pellerito O; Vento R; Calvaruso G; Giuliano M
Int J Oncol; 2016 Mar; 48(3):1039-44. PubMed ID: 26698404
[TBL] [Abstract] [Full Text] [Related]
5. Combined Ablation and Radiation Therapy of Spinal Metastases: A Novel Multimodality treatment Approach.
Greenwood TJ; Wallace A; Friedman MV; Hillen TJ; Robinson CG; Jennings JW
Pain Physician; 2015 Nov; 18(6):573-81. PubMed ID: 26606009
[TBL] [Abstract] [Full Text] [Related]
6. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract] [Full Text] [Related]
7. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
[TBL] [Abstract] [Full Text] [Related]
8. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract] [Full Text] [Related]
9. [Kaposi's sarcoma and organ transplantation: 22 cases].
Bécuwe C; Euvrard S; Bosshard S; Pouteil-Noble C; Garnier JL; Lefrançois N; Boillot O; Kanitakis J; Touraine JL; Claudy A
Ann Dermatol Venereol; 2005 Nov; 132(11 Pt 1):839-43. PubMed ID: 16327712
[TBL] [Abstract] [Full Text] [Related]
10. [Sarcoma of the endometrium. Epidemiology and prognostic factors. Apropos of a study of 22 cases].
Calais G; Frinot-Rousseau S; Body G; Fetissoff F; Le Floch O; Lansac J
J Gynecol Obstet Biol Reprod (Paris); 1989; 18(7):885-9. PubMed ID: 2614028
[TBL] [Abstract] [Full Text] [Related]